SELECT A SPEAKER TO VIEW THEIR BIO.
Breaking News in Chronic Liver Disease
Diagnosing and Managing Cirrhosis and Complications
Clinical Case Forum I: Current and Emerging Management Approaches for the Patient with HRS
Clinical Case Forum II: Inpatient Care and Transition of Care Strategies for the HE Patient
Expert Panel Discussion / Q&A
Kimberly A. Brown, MD, FAST, FAASLD, AGAF
Professor of Medicine Wayne State University Chief, Gastroenterology and Hepatology Associate Medical Director, Henry Ford Hosptial Transplant Institute Henry Ford Hospital Detroit, Michigan
Dr. Kimberly A. Brown is the Chief of Gastroenterology and Hepatology at Henry Ford Hospital in Detroit. She joined the Henry Ford Medical Group in 1995 as Medical Director of the Liver Transplant Program and was appointed Chief of the Division of Gastroenterology and Hepatology in 2003. In addition, she served as the Program Director for the GI Fellowship Program from 2003 to 2008. In 2016 she was appointed as the Associate Medical Director for the Henry Ford Hospital Transplant Institute.
Dr. Brown received her undergraduate degree from the University of Michigan in 1981. She completed her medical degree at Wayne State University in 1985. Dr. Brown completed both her residency in Internal Medicine as well as her fellowship in Gastroenterology at the University of Michigan in 1992 and was named Chief Medical Resident in 1984-85.
Dr. Brown is a member of the American Gastroenterogy Association, the American Association for the Study of Liver Disease, the American College of Gastroenterology and the American Society of Transplantation. She served on the Board of Governors of the Henry Ford Medical Group for 9 years, the Henry Ford Hospital and System Network Board and was past co-chair of the Michigan Chapter of the American Liver Foundation. She was a founding Board Member for the ABIM Liver Transplantation and Advanced Hepatology Board. She is past Treasurer and Board Member of the American Society of Transplantation and is involved with several committees for both the Society and Hospital. She is a past member of the UNOS Liver and Intestines Committee and previously served on the Executive Board for the Liver and Intestines Community of Practice for the AST. She is past associate editor for CLD journal. Currently, Dr. Brown is the Secretary for the AASLD and serves on multiple committees in that capacity.
As Chief of Gastroenterology and Hepatology and past Medical Director of Liver Transplantation, Dr. Brown sees and manages patients with complex liver disease both before and after liver transplantation. In conjunction with Dr. Abouljoud, she worked to develop the leading liver transplant program in the State of Michigan. As fellowship director, she managed a fellowship program of 16 GI/Liver fellows and continues to be involved in structuring and monitoring their education and academic success. Dr. Brown has trained over 110 fellows in advanced hepatology and transplantation. She has published over 70 articles, 110 abstracts and 8 book chapters/reviews and is a very active clinical investigator in viral hepatitis, advanced liver disease and post liver transplant management.
Honoraria recipient: Gilead, Pfizer and Merck.
Research to Institution: Allergan, Conatus, Gilead, and Novartis.
Robert Brown Jr., MD, MPH, AGAF
Gladys and Roland Harriman Professor of Medicine Vice Chair for Mentorship and Academic Development Clinical Chief, Division of Gastroenterology and Hepatology Weill Cornell Medicine New York, New York
Robert S. Brown, Jr., MD, MPH is Vice Chair of Mentorship and Academic Development and Clinical Chief of the Division of Gastroenterology and Hepatology in the Department of Medicine Weill Cornell Medical College in New York, New York. Dr. Brown is the Director of the Center for Liver Disease and Transplantation at New York-Presbyterian Hospital in New York.
Dr. Brown received his bachelor's degree from Harvard College, his medical degree from New York University and his Master of Public Health from the Graduate School of Public Health, University of California in Berkeley. Following the completion of his medical degree, he fulfilled his internship in Medicine at Beth Israel Hospital in Boston and his fellowship in gastroenterology and hepatology at the University of California in San Francisco.
Dr. Brown is an internationally known expert in liver disease and liver transplantation. He has co-authored over 170 peer-reviewed articles most dedicated to viral hepatitis and liver transplantation and has extensive research funding in those areas. He is an Associate Editor for Hepatology and published a book, "Common Liver Diseases and Transplantation: An Algorithmic Approach to Work-up and Management". He was awarded the Young Investigator Award from the American Society of Transplant Physicians, the Senior Attending Teacher Award from Columbia University Medical Center, and the American Liver Foundation New York Chapter's Physician of the Year.
Honoraria recipient: AbbVie, Dova, Gilead, Intercept, Merck and Shionogi, Inc.
Consultant/Research Support: AbbVie, Dova, Gilead, Intercept, Merck and Shionogi, Inc.
Steven Flamm, MD, FAASLD, FACG
Chief of Hepatology and Liver Transplantation Program Professor of Medicine and Surgery Northwestern Feinberg School of Medicine Chicago, Illinois
Steven L. Flamm, MD is a Professor of Medicine and Surgery with the Division of Hepatology at Northwestern University Feinberg School of Medicine in Chicago, Illinois. He serves as the Chief of Transplantation Hepatology and Medical Director of Liver Transplantation.
Dr. Flamm received his MD degree from the University of Pennsylvania School of Medicine. He completed internal medicine training, a chief medical residency year, clinical fellowship in gastroenterology and a research fellowship in gastroenterology and hepatology at Beth Israel Hospital, Harvard Medical School, including a specialized year of training in liver transplantation at The Deaconess Hospital, Harvard Medical School.
Dr. Flamm is a member of the American Gastroenterological Association (AGA), American Association for the Study of Liver Diseases (AASLD), and is a fellow in the American College of Gastroenterology (ACG). He has served as the Region 7 Representative to the UNOS Liver and Intestine Committee and on the Publication and Practice Guidelines Committees of the AASLD. Currently, he is a trustee of the AASLD Foundation and chair of the AASLD Development Committee. Dr. Flamm is also currently a member of the Clinical Practice Guidelines Committee of the AGA, the Research Committee of the ACG, and the Illinois Hepatitis C State Task Force. He serves on the editorial board of Gastroenterology and Hepatology and is the Chair of an AGA abstract review committee.
Dr. Flamm has been the invited editor of three issues of Clinics in Liver Disease and was also the 2015 American Liver Foundation Illinois Chapter Honoree.
Dr. Flamm has published widely in the field of hepatic diseases and has spoken both nationally and internationally on many liver-related topics including viral hepatitis, autoimmune hepatitis, primary biliary cholangitis, hepatic encephalopathy, and liver transplantation. He has an active clinical research program for patients with many different chronic liver diseases including chronic viral hepatitis (HBV and HCV) hepatic encephalopathy, acute liver failure, primary biliary cholangitis and non-alcoholic fatty liver disease (NAFLD).
Honoraria recipient: Dova, and Salix Pharmaceuticals.
Consultant/Research Support: Dova, and Salix Pharmaceuticals.